心律失常引起的心肌病变的患病率:系统性审查和元分析
Teodor Serban1, Tatjana Müller1, Sven Knecht1
1Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
Heart rhythm
|December 6, 2025
概括
心律失常引起的心肌病变 (AiCM) 是左心室缩功能障碍 (LVSD) 的常见原因,在心律失常患者中影响8%的整体和59%的LVSD患者. 为了适当的管理,需要标准化的诊断标准.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心律失常引起的心肌病 (AiCM) 是左心室缩功能障碍 (LVSD) 的可逆原因,与持续的心律失常有关.
- 从历史上看,AiCM一直被低估,其真正的流行率在很大程度上是未知的.
研究的目的:
- 为了确定AiCM在不同患者群体中的患病率.
- 分析患者基线特征如何影响AiCM发展.
- 评估现有临床研究中使用的诊断标准.
主要方法:
- 一个系统的审查和元分析,遵循PRISMA指南.
- 在PubMed,MEDLINE和Embase数据库中进行的搜索.
- 使用纽卡斯尔-太华尺度和ROBINS-I工具进行质量评估;针对流行因素进行元回归.
主要成果:
- 分析了26项涉及7331名患者的研究;整体AiCM患病率为8%,在LVSD队列中升至59%.
- 患病率因心律失常的类型和诊断标准而异.
- 较高的基线心率和特定的患者人口统计学 (年龄,LVEF) 与AiCM相关.
结论:
- 在患有心律失常的患者中,AiCM是LVSD的主要原因.
- 这些发现强调了统一的诊断标准的必要性,以指导有效的患者管理.
相关概念视频
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Cardiomyopathy IV: Restrictive Cardiomyopathy
431
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
431
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Cardiomyopathy II: Dilated Cardiomyopathy
447
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447


